SPONSOR
Dan Zandberg
Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: MelanomaNSCLCHepatocellular CarcinomaUrothelial CancerGastric AdenocarcinomaHNSCCEsophageal AdenocarcinomaMicrosatellite Instability-High Solid Malignant Tumor
Dan Zandberg is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Melanoma, NSCLC, Hepatocellular Carcinoma, Urothelial Cancer.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Dan Zandberg
How many clinical trials has Dan Zandberg sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Dan Zandberg, of which 1 are actively recruiting participants. These trials cover conditions including Melanoma, NSCLC, Hepatocellular Carcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Dan Zandberg research focus on?
Dan Zandberg clinical trials span Melanoma, NSCLC, Hepatocellular Carcinoma, Urothelial Cancer, Gastric Adenocarcinoma, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Dan Zandberg clinical trial?
To participate in a Dan Zandberg trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Dan Zandberg trials with current recruitment status updated daily.
Clinical Trials by Dan Zandberg
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology